Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis I Spuls

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Dermatological Treatment|August 24, 2021
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? - a systematic review with GRADE approachAstrid M van Huizen, Francisca M Vermeulen, Cathelijne M J M Bik, et al.
Journal of the American Academy of Dermatology|June 3, 2020
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Orphanet Journal of Rare Diseases|March 3, 2022
Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysisAnne C Fledderus, Anna Linn Widdershoven, Oren Lapid, et al.
Acta Dermato-Venereologica|November 17, 2025
Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world StudyAnne R Schlösser, Anouk G M Caron, Merle S Den Ouden, et al.
Clinical Drug Investigation|September 23, 2025
Mucous Membrane Pemphigoid Outcome Measurement in Clinical Research: A Scoping ReviewBillal Tedbirt, Eva W H Korte, Marjolein A J Hiel, et al.
The British Journal of Dermatology|November 25, 2025
Bullous Pemphigoid Outcome Measurement: A Scoping Review of Outcome Heterogeneity and Trends in Clinical Research of TreatmentsMarjolein A J Hiel, Billal Tedbirt, Eva W H Korte, et al.
The British Journal of Dermatology|April 18, 2025
Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitionsMarjolein A J Hiel, Eva W H Korte, Billal Tedbirt, et al.
The British Journal of Dermatology|September 19, 2025
Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert surveyEva W H Korte, Marjolein A J Hiel, Maria C Bolling, et al.
Vaccines|May 28, 2022
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive TherapyHannah M Garcia Garrido, Albert Vollaard, Geert R D'Haens, et al.
The British Journal of Dermatology|August 7, 2023
The Harmonising Outcome Measures for Eczema (HOME) implementation roadmapYael A Leshem, Eric L Simpson, Christian Apfelbacher, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Dermatological Treatment|August 24, 2021
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? - a systematic review with GRADE approachAstrid M van Huizen, Francisca M Vermeulen, Cathelijne M J M Bik, et al.
Journal of the American Academy of Dermatology|June 3, 2020
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Orphanet Journal of Rare Diseases|March 3, 2022
Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysisAnne C Fledderus, Anna Linn Widdershoven, Oren Lapid, et al.
Acta Dermato-Venereologica|November 17, 2025
Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world StudyAnne R Schlösser, Anouk G M Caron, Merle S Den Ouden, et al.
Clinical Drug Investigation|September 23, 2025
Mucous Membrane Pemphigoid Outcome Measurement in Clinical Research: A Scoping ReviewBillal Tedbirt, Eva W H Korte, Marjolein A J Hiel, et al.
The British Journal of Dermatology|November 25, 2025
Bullous Pemphigoid Outcome Measurement: A Scoping Review of Outcome Heterogeneity and Trends in Clinical Research of TreatmentsMarjolein A J Hiel, Billal Tedbirt, Eva W H Korte, et al.
The British Journal of Dermatology|April 18, 2025
Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitionsMarjolein A J Hiel, Eva W H Korte, Billal Tedbirt, et al.
The British Journal of Dermatology|September 19, 2025
Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert surveyEva W H Korte, Marjolein A J Hiel, Maria C Bolling, et al.
Vaccines|May 28, 2022
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive TherapyHannah M Garcia Garrido, Albert Vollaard, Geert R D'Haens, et al.
The British Journal of Dermatology|August 7, 2023
The Harmonising Outcome Measures for Eczema (HOME) implementation roadmapYael A Leshem, Eric L Simpson, Christian Apfelbacher, et al.
Pageof 13